Genus Plc logo

Genus Plc(LSE) GNS

Market Cap£1.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1998)+2,298%
5 Year-59%
1 Year-12%
1 Month-4%
£22.08
+4.45%
+0.94Today
Genus Plc last closing stock price
MetricPriceDate
Last closeGBX 2,190.002026-10-07
Genus Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.24%GBX 2,142.002026-09-30
1 month-3.86%GBX 2,278.002026-09-07
3 month+5.69%GBX 2,072.002026-07-09
Year to date-15.61%GBX 2,595.002025-12-31
1 year-12.4%GBX 2,500.002025-10-07
3 year+2.53%GBX 2,136.002023-10-06
5 year-58.76%GBX 5,310.002021-10-08
Since inception+2,297.56%GBX 0.881998-01-30

Genus Plc Financials at a Glance

Market Cap

£1.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£1.33B

Net Income (TTM)

£304.60M

EPS (TTM)

£4.25

P/E Ratio

4.93

Dividend

£0.33

Beta (Volatility)

-0.02 (Low)

Price

£22.08

Volume

250,165

Open

£21.82

Previous Close

£22.08

Daily Range

£21.13 - £22.08

52-Week Range

£19.43 - £32.20

Estimated Earnings Date

Feb 25, 2027

GNS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genus Plc

Genus plc is a global leader in animal genetics, specializing in the breeding of livestock to enhance agricultural productivity. The company operates across multiple regions, including North America, Europe, and Asia, and is committed to advancing animal health and welfare through innovative genetic solutions.

Products and Services
  • Breeding stock for pigs, including sows, boars, and semen
  • Genetic solutions for cattle, offering bull semen and embryos
  • Specialized technical services, such as semen sexing and reproductive solutions
Growth Outlook
  • Strategic collaboration with Beijing Capital Agribusiness for PRRSV-resistant pigs
  • Expansion into emerging markets, enhancing global reach and revenue potential
  • Continued investment in R&D to drive innovation and product development
Financial Highlights
  • Recent quarterly revenue of £322.5 million, showcasing strong market demand
  • Trailing twelve months (TTM) net income margin of 43.35%, indicating robust profitability
  • Dividend yield of 1.49%, reflecting commitment to shareholder returns
Genus plc operates in the biotechnology sector, focusing on animal genetics to improve livestock production efficiency. The company is divided into three segments: Genus PIC, Genus ABS, and Genus Research and Development. Each segment plays a crucial role in providing farmers with high-quality breeding stock and technical services. The recent collaboration with Beijing Capital Agribusiness highlights Genus's commitment to innovation, particularly in developing disease-resistant livestock, which is essential for enhancing food security. Financially, Genus has demonstrated resilience, with a recent quarterly revenue of £322.5 million, reflecting strong demand for its products. The TTM net income margin of 43.35% underscores the company's ability to maintain profitability amidst market fluctuations. Additionally, the dividend yield of 1.49% signals a commitment to returning value to shareholders, making Genus an attractive option for investors interested in the biotechnology sector. Overall, Genus plc presents a compelling opportunity for those looking to invest in a company at the forefront of agricultural innovation.
AI Generated • Oct 5, 2026

Industry

Biotechnology

Sector

Health Care

Employees

3,307

CEO

Jorgen Kokke

Website

www.genusplc.com

Headquarters

Basingstoke, HM RG21 4FF, GB

GNS Financials

Key Financial Metrics (TTM)

Gross Margin

96.72%

Operating Margin

13.27%

Net Income Margin

43.35%

Return on Equity

44.90%

Return on Capital

9.99%

Return on Assets

28.02%

Earnings Yield

20.28%

Dividend Yield

1.56%

Payout Ratio

7.61%

Stock Overview

Market Cap

£1.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

66.15M

Volume

250.16K

Avg. Volume

205.09K

Financials (TTM)

Gross Profit

£1.31B

Operating Income

£129.70M

EBITDA

£213.30M

Operating Cash Flow

£163.80M

Capital Expenditure

-£25.90M

Free Cash Flow

£137.90M

Cash & ST Invst.

£43.70M

Total Debt

£107.50M

Genus Plc Performance Analysis

Genus Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30GBP 689,700,00016.2%
20242024-06-30GBP 668,800,000-3.0%
20252025-06-30GBP 672,800,0000.6%
20262026-06-30GBP 658,100,000-2.2%
Genus Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-310.4%
Q42025-06-30N/A
Q22025-12-31-0.2%
Q42026-06-30-3.9%
Genus Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30GBP 0.50-18.9%
20242024-06-30GBP 0.12-76.3%
20252025-06-30GBP 0.29141.9%
20262026-06-30GBP 4.251372.0%
Genus Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31128.5%
Q42025-06-301020.3%
Q22025-12-3163.0%
Q42026-06-30765.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

£322.50M

-3.8%

Gross Profit

£322.50M

-3.8%

Gross Margin

100.00%

N/A

Market Cap

£1.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£438.39K

N/A

Employees

3,190

N/A

Net Income

£255.50M

+4662.5%

EBITDA

£67.10M

+493.8%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

£43.70M

+2.8%

Total Debt

£107.50M

-63.1%

Accounts Receivable

£122.60M

+0.1%

Inventory

£83.70M

-6.4%

Long Term Debt

£93.40M

-65.7%

Short Term Debt

£14.10M

-25.4%

Return on Assets

28.02%

N/A

Return on Invested Capital

9.69%

N/A

Free Cash Flow

£60.40M

+235.6%

Operating Cash Flow

£67.60M

+184.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PRTC.LPureTech Health plc
£1.10+1.10%
BVXP.LBioventix PLC
£17.50+1.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$113.12+0.55%
NUNu Holdings
$15.58-0.51%
NVDANvidia
$237.47-0.74%
BULLWebull
$5.89-19.09%

Questions About GNS

What is the current price of Genus Plc?

Genus Plc is trading at £22.08 per share.

What is the 52-week range for Genus Plc?

Over the past 52 weeks, Genus Plc has traded between £19.43 and £32.20.

How much debt does Genus Plc have?

As of the most recent reporting period, Genus Plc reported total debt of £107.50M.

How much cash does Genus Plc have on hand?

Genus Plc reported £43.70M in cash and cash equivalents in its most recent financial results.

What is Genus Plc’s dividend yield?

Genus Plc currently has a dividend yield of 1.56%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services